Laura Perna1, Hans-Werner Wahl2, Ute Mons1, Kai-Uwe Saum1, Bernd Holleczek3, Hermann Brenner1. 1. German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research, Im Neuenheimer Feld 581-69120 Heidelberg, Germany. 2. Department of Psychological Aging Research, Institute of Psychology, Heidelberg University, Hauptstrasse 47-51-69117 Heidelberg, Germany. 3. Saarland Cancer Registry, Präsident Baltz Straβe 5-66119 Saarbrücken, Germany.
Abstract
BACKGROUND: cognitive impairment is widespread among older adults even in the absence of dementia, but very little is known about the association between cognitive impairment not due or not yet converted to dementia and mortality. The association between cognitive impairment and mortality contributes to assessing cognitive impairment-related risk constellation in old age in the absence of manifest dementia. OBJECTIVE: to assess the impact of cognitive impairment on all-cause and cause-specific mortality among non-demented older adults and to explore the nature of the association between cognitive impairment and mortality. DESIGN: an observational cohort study (ESTHER study; 2000-present). SETTING: German state of Saarland. SUBJECTS: a subsample of 1,622 participants aged ≥70 with measurement of cognitive function through the Cognitive Telephone Screening Instrument (COGTEL) and exclusion of a possible dementia diagnosis at both COGTEL baseline (2005-08) and over the mortality follow-up (2005-13). RESULTS: during an average follow-up of 6.1 years, 231 participants (14.2%) died. Participants with low COGTEL total scores had ∼60% increased mortality compared with participants with higher COGTEL total scores in Cox regression models adjusting for a wide range of possible confounders (hazard ratio = 1.62; confidence interval 1.13-2.33). Dose-response analyses with restricted cubic splines indicate a monotonic inverse relationship between cognitive function and mortality. CONCLUSION: cognitive impairment in the absence of manifest dementia is an important independent predictor of mortality, especially among men. The administration of cognitive tests among older adults may provide relevant information for patient care and treatment decisions. SOURCES OF FUNDING: financial sponsors played no role in the design, execution, analysis and interpretation of data.
BACKGROUND: cognitive impairment is widespread among older adults even in the absence of dementia, but very little is known about the association between cognitive impairment not due or not yet converted to dementia and mortality. The association between cognitive impairment and mortality contributes to assessing cognitive impairment-related risk constellation in old age in the absence of manifest dementia. OBJECTIVE: to assess the impact of cognitive impairment on all-cause and cause-specific mortality among non-demented older adults and to explore the nature of the association between cognitive impairment and mortality. DESIGN: an observational cohort study (ESTHER study; 2000-present). SETTING: German state of Saarland. SUBJECTS: a subsample of 1,622 participants aged ≥70 with measurement of cognitive function through the Cognitive Telephone Screening Instrument (COGTEL) and exclusion of a possible dementia diagnosis at both COGTEL baseline (2005-08) and over the mortality follow-up (2005-13). RESULTS: during an average follow-up of 6.1 years, 231 participants (14.2%) died. Participants with low COGTEL total scores had ∼60% increased mortality compared with participants with higher COGTEL total scores in Cox regression models adjusting for a wide range of possible confounders (hazard ratio = 1.62; confidence interval 1.13-2.33). Dose-response analyses with restricted cubic splines indicate a monotonic inverse relationship between cognitive function and mortality. CONCLUSION: cognitive impairment in the absence of manifest dementia is an important independent predictor of mortality, especially among men. The administration of cognitive tests among older adults may provide relevant information for patient care and treatment decisions. SOURCES OF FUNDING: financial sponsors played no role in the design, execution, analysis and interpretation of data.
Authors: Liming Dong; William W Eaton; Adam P Spira; Jacqueline Agnew; Pamela J Surkan; Ramin Mojtabai Journal: Occup Environ Med Date: 2018-10-15 Impact factor: 4.402
Authors: Maria Theresa D Opina; Barbara J Nicklas; James F Lovato; Daniel C Files; Stephen B Kritchevsky; Wendy C Moore Journal: J Am Geriatr Soc Date: 2019-06-27 Impact factor: 5.562
Authors: Nicholas K Schiltz; David F Warner; Jiayang Sun; Kathleen A Smyth; Stefan Gravenstein; Kurt C Stange; Siran M Koroukian Journal: J Aging Health Date: 2018-01-18
Authors: Melanie J Koren; Helena M Blumen; Emmeline I Ayers; Joe Verghese; Matthew K Abramowitz Journal: Clin J Am Soc Nephrol Date: 2021-04-06 Impact factor: 8.237